U.S. Energy Services Stock News

Anyone interested in Taylor Devices, Inc. ( NASDAQ:TAYD ) should probably be aware that the Independent Director, Fritz...

With the business potentially at an important milestone, we thought we'd take a closer look at Candel Therapeutics...

Key Insights The considerable ownership by individual investors in SANUWAVE Health indicates that they collectively...

Argan, Inc. ( NYSE:AGX ) shareholders have had their patience rewarded with a 29% share price jump in the last month...

Powell Industries, Inc. ( NASDAQ:POWL ) shareholders have had their patience rewarded with a 32% share price jump in...

Park Aerospace Corp. ( NYSE:PKE ) shareholders have had their patience rewarded with a 25% share price jump in the last...

We feel now is a pretty good time to analyse AVITA Medical, Inc.'s ( NASDAQ:RCEL ) business as it appears the company...

If you are wondering whether Recursion Pharmaceuticals' current share price gives you enough value for the risk you are taking, you are not alone. The stock closed at US$4.67, with returns of 0.2% over the last 7 days, a 0.2% decline over 30 days, an 11.2% gain year to date, and a 28.5% decline over the past year, which can change how investors think about both potential and risk. Recent attention on Recursion has focused on its position within the pharmaceuticals and biotech space and how...

United Airlines recently rolled out a preorder system for fresh Economy meals on flights over 1,190 miles, with preordering becoming the only way to buy these entrees from March 1, 2026, via its website and mobile app. This shift aims to cut food waste by more than 100,000 pounds annually while sharpening catering efficiency and tailoring choices to customer demand. We’ll now examine how this new meal preorder model, especially its focus on waste reduction and efficiency, could influence...

Organogenesis Holdings Inc. ( NASDAQ:ORGO ) shareholders won't be pleased to see that the share price has had a very...

Conference spotlight and recent stock moves Rush Street Interactive (RSI) is entering a busy stretch of investor visibility, with presentations scheduled at the ICR Conference in Orlando on January 12 and the Needham Growth Conference in New York on January 15. These appearances come shortly after analyst reports highlighted improved growth prospects tied to recent tax changes in Colombia and the possibility of entry into new regulated online gaming markets such as Alberta and Maine. See our...

Recent analyst downgrades of Lineage (LINE), including a shift by Barclays to a more neutral stance, have put the stock in focus as investors reassess expectations around the company’s outlook and upcoming catalysts. See our latest analysis for Lineage. At a last close of US$36.34, Lineage’s recent share price return has been mixed, with a 4.43% 1 month gain, a 90 day share price return of 8.81%, and a 1 year total shareholder return loss of 34.36%. This suggests momentum has been fading as...

On January 14, 2026, Block, Inc. entered into an Amended and Restated Revolving Credit Agreement with Goldman Sachs Bank USA and other lenders, lifting its unsecured revolving loan facility from US$775.0 million to US$900.0 million and extending potential access to this funding through January 14, 2031, subject to liquidity conditions tied to its existing notes. This expanded, currently undrawn credit facility gives Block additional flexibility to fund working capital and general corporate...

Why Floor & Decor Holdings (FND) Is On Investors’ Radar Floor & Decor Holdings (FND) has drawn attention after a strong month, with the share price return sitting around 26% and roughly 7% over the past week. This recent performance is inviting closer scrutiny of what is driving sentiment. See our latest analysis for Floor & Decor Holdings. That 25.69% 1 month share price return to about $76.07 comes after a 20.80% year to date share price return, yet the 1 year total shareholder return of...

Insulet (PODD) used its slot at the J.P. Morgan Healthcare Conference to spotlight past growth trends, detail its Omnipod product roadmap, and lay out ambitions to reach a much larger diabetes population. See our latest analysis for Insulet. Insulet’s recent conference appearances and product roadmap have arrived after a 90 day share price return of a 9.7% decline and a 1 year total shareholder return of 4.31%, which together suggest recent momentum has cooled compared to longer term...

Wells Fargo & Company ( NYSE:WFC ) shareholders are probably feeling a little disappointed, since its shares fell 7.9...

Gibraltar Industries recently presented at CJS Securities’ 26th Annual “New Ideas for the New Year” Investor Conference on January 14, 2026, with CEO William T. Bosway and CFO Joseph Allen Lovechio outlining the company’s priorities. Management emphasized a sharper focus on residential building products and structures, including the planned divestiture of the renewables segment to simplify operations and pursue more consistent returns. We’ll now examine how this refocus on residential...

If you are wondering whether Nova's share price still represents good value or if expectations have run ahead of reality, you are not alone. Nova's recent share price moves have been strong, with the stock at US$445.70 and total returns of 13.1% over 7 days, 48.1% over 30 days, 28.3% year to date, 82.0% over 1 year, 380.8% over 3 years and a very large gain over 5 years. These returns have put Nova firmly on many investors' radar, prompting closer attention to what is driving the story...

If you are wondering whether Southern Copper's current share price still offers value, you are not alone. The answer depends heavily on how you look at its valuation. The stock most recently closed at US$180.95, with returns of 6.1% over 7 days, 27.9% over 30 days, 21.7% year to date, 96.9% over 1 year, 183.4% over 3 years, and 234.6% over 5 years. These figures naturally raise questions about how much optimism is already priced in. Recent news coverage has largely focused on Southern Copper...

Why Incyte (INCY) Is On Investors' Radar Today Incyte (INCY) is back in focus after recent share price moves and fresh attention on its pipeline and existing therapies. The stock’s performance over the past month and past 3 months is drawing closer scrutiny from investors. See our latest analysis for Incyte. Recent trading has been choppy, but the trend over the past few months has been positive. The 30 day share price return is 8.79% and the 90 day share price return is 21.29%, while the 1...

Why Adams Diversified Equity Fund Is On Investors’ Radar Adams Diversified Equity Fund (ADX) has attracted attention after recent share price moves, with a 1 day return near flat, a small pullback over the past week, and gains over the past month and past 3 months. With the fund trading around $23.12 and an indicated intrinsic discount of about 50%, investors are weighing how its long operating history and diversified equity approach might fit into a broader portfolio that focuses on listed...

In recent months, AutoZone’s earnings were pressured by higher operating expenses and a large non-cash LIFO inventory charge tied to more than 140 new store openings and new supply chain hubs, even as the company continued adding locations such as its future largest Lima store on a former Rite Aid site. While these expansion-related costs weighed on reported results and investor sentiment, several institutional investors and research firms still highlight AutoZone’s strong underlying...

Why Toast’s latest news matters for investors Toast (TOST) is back in focus after rolling out new AI powered tools for retailers and appointing Mastercard veteran Rossana Niola as Chief Accounting Officer, a combination that touches both product direction and financial oversight. For investors, this pairing of product updates and leadership change offers a fresh chance to look at how Toast’s retail ambitions sit alongside its core restaurant platform and recent profitability, as well as what...

SS Innovations International (SSII) caught investors’ attention after issuing preliminary 2025 revenue guidance that points to record sales of its SSi Mantra surgical robotic systems, supported by higher installations in India and abroad. See our latest analysis for SS Innovations International. The guidance arrived after a sharp move in the shares, with a 1 day share price return of 7.43% and a 7 day share price return of 7.43%. However, the 90 day share price return of a 39.12% decline and...